CIRC Reports No Share Capital Changes in October 2026 Monthly Return

Bulletin Express11-03

China Isotope & Radiation Corporation (CIRC) filed its Monthly Return for the period ended 31 October 2026, confirming that both its authorised and issued share capital remained unchanged during the month.

Authorised / Registered Capital • H Shares: 79.97 million shares with a par value of RMB1 each, unchanged from September. • Domestic Shares: 239.91 million shares with a par value of RMB1 each, unchanged from September. • Total authorised share capital stood at RMB319.87 million.

Issued Shares and Public Float • H Shares in issue (excluding treasury shares) remained at 79.97 million; no treasury shares were held. • Domestic Shares in issue totalled 239.91 million; no treasury shares were held. • The company confirmed compliance with the Main Board’s minimum 25% public-float requirement for its H Share class.

Capital-Raising Instruments • The filing reports no activity in share options, warrants, convertibles or other equity-linked instruments during the month. • There were no Hong Kong Depositary Receipts outstanding or issued.

Governance Confirmation The submission, signed by Joint Company Secretary Ms Wang Cangren on 3 November 2026, attests that all regulatory and listing rule obligations were met and that there were no new issues, repurchases or cancellations requiring disclosure.

Overall, CIRC’s capital structure and share count were static through October 2026, reflecting a stable equity position with full adherence to Hong Kong Stock Exchange requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment